Novartis Investigative Site — Fayetteville, Arkansas

Novartis Investigative Site is a clinical research site located in Fayetteville, Arkansas, United States 72703.

Crixeo Health Trust Score: 68/100 (FAIR). This profile has not yet been claimed by the site owner.

Novartis Investigative Site has participated in 5 clinical trials.

Therapeutic areas: Metastatic Renal Cell Carcinoma, Multiple Myeloma, Neoplasms, Breast.

Sponsors: Novartis Pharmaceuticals, pharmaand GmbH, Novartis.

Sponsor Feasibility Report

Trust Score: 68/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Novartis Investigative Site?

Novartis Investigative Site has a Crixeo Trust Score of 68/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Novartis Investigative Site conducted?

Novartis Investigative Site has 5 clinical trials on record. Their work covers Metastatic Renal Cell Carcinoma, Multiple Myeloma, Neoplasms, Breast.

Is Novartis Investigative Site accredited by Crixeo Health?

Novartis Investigative Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Novartis Investigative Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.